Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Not only was the distribution of patients with T-ALL different over the MRD-based risk groups, the prognostic value of MRD levels at TP1 and TP2 was higher in T-ALL (larger RFS gradient), and consistently higher RFS rates were found for MRD-negative T-ALL patients at the first 5 follow-up time points.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP566113.RACrFVMI7ZEPUrbwamIXZu4tQVh22isXWkdU58ZiSSMNI130_assertion description "[Not only was the distribution of patients with T-ALL different over the MRD-based risk groups, the prognostic value of MRD levels at TP1 and TP2 was higher in T-ALL (larger RFS gradient), and consistently higher RFS rates were found for MRD-negative T-ALL patients at the first 5 follow-up time points.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP566113.RACrFVMI7ZEPUrbwamIXZu4tQVh22isXWkdU58ZiSSMNI130_provenance.
• NP940024.RAolt_4BEwYxJ5jO9OmmdMQakr5EDbS4EnrJ-4T0yRLsU130_assertion description "[Not only was the distribution of patients with T-ALL different over the MRD-based risk groups, the prognostic value of MRD levels at TP1 and TP2 was higher in T-ALL (larger RFS gradient), and consistently higher RFS rates were found for MRD-negative T-ALL patients at the first 5 follow-up time points.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP940024.RAolt_4BEwYxJ5jO9OmmdMQakr5EDbS4EnrJ-4T0yRLsU130_provenance.
• NP279434.RAxHmZveGQYKjHrWRSIoAKcD395xrmRG4aC8XngWXIlX8130_assertion description "[Not only was the distribution of patients with T-ALL different over the MRD-based risk groups, the prognostic value of MRD levels at TP1 and TP2 was higher in T-ALL (larger RFS gradient), and consistently higher RFS rates were found for MRD-negative T-ALL patients at the first 5 follow-up time points.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP279434.RAxHmZveGQYKjHrWRSIoAKcD395xrmRG4aC8XngWXIlX8130_provenance.
• NP240994.RAEdd73zES1IFSU2xcw3PnpMtFm1_rPXnNUKIwVxsP01U130_assertion description "[Not only was the distribution of patients with T-ALL different over the MRD-based risk groups, the prognostic value of MRD levels at TP1 and TP2 was higher in T-ALL (larger RFS gradient), and consistently higher RFS rates were found for MRD-negative T-ALL patients at the first 5 follow-up time points.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP240994.RAEdd73zES1IFSU2xcw3PnpMtFm1_rPXnNUKIwVxsP01U130_provenance.
• NP301283.RAU8sTGlY9U-gDexL7Mn0xMBZnndoDPtYOFib8g5KJYHo130_assertion description "[Not only was the distribution of patients with T-ALL different over the MRD-based risk groups, the prognostic value of MRD levels at TP1 and TP2 was higher in T-ALL (larger RFS gradient), and consistently higher RFS rates were found for MRD-negative T-ALL patients at the first 5 follow-up time points.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP301283.RAU8sTGlY9U-gDexL7Mn0xMBZnndoDPtYOFib8g5KJYHo130_provenance.
• NP497353.RAnBJza7rPIMTL3AjK_2HKVgheXu84R-YhEzWNNL1Sx1I130_assertion description "[Not only was the distribution of patients with T-ALL different over the MRD-based risk groups, the prognostic value of MRD levels at TP1 and TP2 was higher in T-ALL (larger RFS gradient), and consistently higher RFS rates were found for MRD-negative T-ALL patients at the first 5 follow-up time points.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP497353.RAnBJza7rPIMTL3AjK_2HKVgheXu84R-YhEzWNNL1Sx1I130_provenance.
• NP647498.RAOB2VFHnIDJF4tzpAikccWrhGvuUoaN9JDRKIzPaNfME130_assertion description "[Not only was the distribution of patients with T-ALL different over the MRD-based risk groups, the prognostic value of MRD levels at TP1 and TP2 was higher in T-ALL (larger RFS gradient), and consistently higher RFS rates were found for MRD-negative T-ALL patients at the first 5 follow-up time points.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP647498.RAOB2VFHnIDJF4tzpAikccWrhGvuUoaN9JDRKIzPaNfME130_provenance.
• NP653891.RAMlhrczMii_s4v4fV0_T_mdSWmEHFCkHGkx1AbbSg0jA130_assertion description "[Not only was the distribution of patients with T-ALL different over the MRD-based risk groups, the prognostic value of MRD levels at TP1 and TP2 was higher in T-ALL (larger RFS gradient), and consistently higher RFS rates were found for MRD-negative T-ALL patients at the first 5 follow-up time points.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP653891.RAMlhrczMii_s4v4fV0_T_mdSWmEHFCkHGkx1AbbSg0jA130_provenance.
• NP657231.RAHsTl9JpKhtUrD-H6aSog66z6rOoDxnaYpbD5INJeRWE130_assertion description "[Not only was the distribution of patients with T-ALL different over the MRD-based risk groups, the prognostic value of MRD levels at TP1 and TP2 was higher in T-ALL (larger RFS gradient), and consistently higher RFS rates were found for MRD-negative T-ALL patients at the first 5 follow-up time points.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP657231.RAHsTl9JpKhtUrD-H6aSog66z6rOoDxnaYpbD5INJeRWE130_provenance.
• NP874962.RAM1YRvq6yLsz3yxUxkZ7XgbudLR3ZX_vEpooeK1myQnk130_assertion description "[Not only was the distribution of patients with T-ALL different over the MRD-based risk groups, the prognostic value of MRD levels at TP1 and TP2 was higher in T-ALL (larger RFS gradient), and consistently higher RFS rates were found for MRD-negative T-ALL patients at the first 5 follow-up time points.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP874962.RAM1YRvq6yLsz3yxUxkZ7XgbudLR3ZX_vEpooeK1myQnk130_provenance.